{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:46:41Z","timestamp":1793969201157,"version":"4.8.0"},"reference-count":230,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Autism spectrum disorder (ASD) and Alzheimer\u2019s disease (AD) are neurodevelopmental and neurodegenerative disorders affecting two opposite ends of life span, i.e., childhood and old age. Both disorders pose a cumulative threat to human health, with the rate of incidences increasing considerably worldwide. In the context of recent developments, we aimed to review correlated symptoms and genetics, and overlapping aspects in the mechanisms of the pathogenesis of ASD and AD. Dementia, insomnia, and weak neuromuscular interaction, as well as communicative and cognitive impairments, are shared symptoms. A number of genes and proteins linked with both disorders have been tabulated, including MECP2, ADNP, SCN2A, NLGN, SHANK, PTEN, RELN, and FMR1. Theories about the role of neuron development, processing, connectivity, and levels of neurotransmitters in both disorders have been discussed. Based on the recent literature, the roles of FMRP (Fragile X mental retardation protein), hnRNPC (heterogeneous ribonucleoprotein-C), IRP (Iron regulatory proteins), miRNAs (MicroRNAs), and \u03b1-, \u03b20, and \u03b3-secretases in the posttranscriptional regulation of cellular synthesis and processing of APP (amyloid-\u03b2 precursor protein) have been elaborated to describe the parallel and overlapping routes and mechanisms of ASD and AD pathogenesis. However, the interactive role of genetic and environmental factors, oxidative and metal ion stress, mutations in the associated genes, and alterations in the related cellular pathways in the development of ASD and AD needs further investigation.<\/jats:p>","DOI":"10.3390\/biom11111635","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T09:11:32Z","timestamp":1636017092000},"page":"1635","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4112-0925","authenticated-orcid":false,"given":"Muhammad Shahid","family":"Nadeem","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0639-1618","authenticated-orcid":false,"given":"Salman","family":"Hosawi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0922-9819","authenticated-orcid":false,"given":"Sultan","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-4373","authenticated-orcid":false,"given":"Mohammed M.","family":"Ghoneim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8913-0826","authenticated-orcid":false,"given":"Syed Sarim","family":"Imam","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi Nazia","family":"Murtaza","sequence":"additional","affiliation":[{"name":"Department of Zoology, Abbottabad University of Science and Technology (AUST), Abbottabad 22310, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-5219","authenticated-orcid":false,"given":"Imran","family":"Kazmi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-017-1736-4","article-title":"Autism spectrum disorder: Neuropathology and animal models","volume":"134","author":"Varghese","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2174\/1381612827666210120095829","article-title":"Autism-A Comprehensive Array of Prominent Signs and Symptoms","volume":"27","author":"Nadeem","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_4","first-page":"59","article-title":"Multivariate neural connectivity patterns in early infancy predict later autism symptoms","volume":"6","author":"Dickinson","year":"2021","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1381612826666200226101218","article-title":"Multiple risk factors: A challenge in the management of Autism","volume":"26","author":"Nadeem","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/YCO.0000000000000673","article-title":"Prenatal and perinatal metabolic risk factors for autism: A review and integration of findings from population-based studies","volume":"34","author":"Katz","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s40520-020-01774-y","article-title":"The prevalence and co-incidence of geriatric syndromes in older patients with early-stage Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"33","author":"Soysal","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rajan, K.B., Weuve, J., Barnes, L.L., McAninch, E.A., Wilson, R.S., and Evans, D.A. (2021). Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020\u20132060). Alzheimers Dement.","DOI":"10.1002\/alz.12362"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100105","DOI":"10.1074\/jbc.REV120.008207","article-title":"The essential elements of Alzheimer\u2019s disease","volume":"296","author":"Lei","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimers Dement."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pereira, J.B., Janelidze, S., Smith, R., Mattsson-Carlgren, N., Palmqvist, S., Teunissenm, C.E., Zetterberg, H., Stomrud, E., Ashton, N.J., and Blennow, K. (2021). Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease. Brain, 14.","DOI":"10.1101\/2021.04.11.21255152"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41398-021-01206-z","article-title":"Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer\u2019s disease","volume":"11","author":"Johansson","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/13803395.2018.1446513","article-title":"Connected speech and language in mild cognitive impairment and Alzheimer\u2019s disease: A review of picture description tasks","volume":"40","author":"Mueller","year":"2018","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/WAD.0000000000000345","article-title":"Behaviors characteristic of autism spectrum disorder in a geriatric cohort with mild cognitive impairment or early dementia","volume":"34","author":"Rhodus","year":"2020","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1037\/neu0000621","article-title":"Narrative video scene description task discriminates between levels of cognitive impairment in Alzheimer\u2019s disease","volume":"34","author":"Reeves","year":"2020","journal-title":"Neuropsychology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/1871527319666200628015039","article-title":"Inflammation and mitochondrial dysfunction in autism spectrum disorder","volume":"19","author":"Gevezova","year":"2020","journal-title":"CNS Neurol. Disord.-Drug Targets"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5483\/BMBRep.2020.53.1.274","article-title":"Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer\u2019s disease","volume":"53","author":"Yoo","year":"2020","journal-title":"BMB Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1038\/cddis.2014.227","article-title":"Altered expression of Alzheimer\u2019s disease-related genes in the cerebellum of autistic patients: A model for disrupted brain connectome and therapy","volume":"5","author":"Salmina","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1700054","DOI":"10.1002\/bies.201700054","article-title":"ADNP plays a key role in autophagy: From autism to schizophrenia and Alzheimer\u2019s disease","volume":"39","author":"Sragovich","year":"2017","journal-title":"Bioessays"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41380-020-00928-8","article-title":"How autism and Alzheimer\u2019s disease are TrAPPed","volume":"26","author":"Lahiri","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113591","DOI":"10.1016\/j.psychres.2020.113591","article-title":"Use of psychotropic agents to treat agitation and aggression in Brazilian patients with Alzheimer\u2019s disease: A naturalistic and multicenter study","volume":"295","author":"Camargos","year":"2021","journal-title":"Psychiatry Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/HRP.0000000000000282","article-title":"Treatment of aggression in adults with autism spectrum disorder: A review","volume":"29","author":"Im","year":"2021","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12955-021-01669-0","article-title":"Impact of antipsychotics in children and adolescents with autism spectrum disorder: A systematic review and meta-analysis","volume":"19","author":"Amato","year":"2021","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Nanjappa, M.S., Voyiaziakis, E., Pradhan, B., and Thippaiah, S.M. (2020). Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: A clinical review. CNS Spectr., 1\u20138.","DOI":"10.1017\/S109285292000214X"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2174\/1570159X19666210303121059","article-title":"Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis","volume":"19","author":"Leshem","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neurol.2019.07.025","article-title":"Melatonin: A review of its potential functions and effects on neurological diseases","volume":"176","author":"Gunata","year":"2020","journal-title":"Rev. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lalanne, S., Fougerou-Leurent, C., Anderson, G.M., Schroder, C.M., Nir, T., Chokron, S., Delormem, R., Claustrat, B., Bellissant, E., and Kermarrec, S. (2021). Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031490"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1203\/PDR.0b013e318212f16b","article-title":"Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders","volume":"69","author":"Frye","year":"2011","journal-title":"Pediatric Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/ene.12954","article-title":"Peripheral neuropathy is a common manifestation of mitochondrial diseases: A single-centre experience","volume":"23","author":"Luigetti","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.clinph.2018.04.755","article-title":"Small fibre neuropathy in mitochondrial diseases explored with sudoscan","volume":"129","author":"Luigetti","year":"2018","journal-title":"Clin. Neurophysiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/dmcn.14558","article-title":"Autism and attention-deficit\/hyperactivity disorders and symptoms in children with neurofibromatosis type 1","volume":"63","author":"Morotti","year":"2021","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2174\/1570159X18666200203101828","article-title":"A comprehensive review of Alzheimer\u2019s association with related proteins: Pathological role and therapeutic significance","volume":"18","author":"Kumar","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.73.4.371","article-title":"Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer\u2019s disease","volume":"73","author":"Ikeda","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-1781(02)00094-X","article-title":"The stereotypy rating inventory for frontotemporal lobar degeneration","volume":"110","author":"Shigenobu","year":"2002","journal-title":"Psychiatry Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sakuta, S., Hashimoto, M., Ikeda, M., Koyama, A., Takasaki, A., Hotta, M., Fukuhara, R., Ishikawa, T., Yuki, S., and Miyagawa, Y. (2021). Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0247184"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101269","DOI":"10.1016\/j.arr.2021.101269","article-title":"Is personality associated with dementia risk? A meta-analytic investigation","volume":"6","author":"Aschwanden","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1523\/JNEUROSCI.0730-11.2011","article-title":"Stress acts cumulatively to precipitate Alzheimer\u2019s disease-like tau pathology and cognitive deficits","volume":"25","author":"Sotiropoulos","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Castillo, M.A., Urdaneta, K.E., Sempr\u00fan-Hern\u00e1ndez, N., Brigida, A.L., Antonucci, N., Schultz, S., and Siniscalco, D. (2019). Speech-stimulating substances in autism spectrum disorders. Behav. Sci., 9.","DOI":"10.3390\/bs9060060"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/aur.1334","article-title":"Minimally verbal school-aged children with autism spectrum disorder: The neglected end of the spectrum","volume":"6","author":"Kasari","year":"2013","journal-title":"Autism Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Reindal, L., N\u00e6rland, T., Weidle, B., Lydersen, S., Andreassen, O.A., and Sund, A.M. (2021). Structural and Pragmatic Language Impairments in Children Evaluated for Autism Spectrum Disorder (ASD). J. Autism Dev. Dis., 1\u20139.","DOI":"10.1007\/s10803-020-04853-1"},{"key":"ref_44","first-page":"366","article-title":"Primary progressive aphasia: From syndrome to disease","volume":"28","year":"2013","journal-title":"Neurolog\u00eda"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"a006171","DOI":"10.1101\/cshperspect.a006171","article-title":"The neuropsychological profile of Alzheimer disease","volume":"2","author":"Weintraub","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2014.06.004","article-title":"Innovative diagnostic tools for early detection of Alzheimer\u2019s disease","volume":"11","author":"Laske","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1567205014666170829112439","article-title":"Voice markers of lexical access in mild cognitive impairment and Alzheimer\u2019s disease","volume":"15","author":"Meilan","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Pastoriza-Dominguez, P., Torre, I.G., Dieguez-Vide, F., Gomez-Ruiz, I., Gelado, S., Bello-Lopez, J., Avila-Rivera, A., Matias-Guiu, J., Pytel, V., and Hernandez-Fernandez, A. (2021). Speech pause distribution as an early marker for Alzheimer\u2019s disease. medRxiv.","DOI":"10.1101\/2020.12.28.20248875"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"101198","DOI":"10.1016\/j.csl.2021.101198","article-title":"Paralinguistic and linguistic fluency features for Alzheimer\u2019s disease detection","volume":"68","author":"Campbell","year":"2021","journal-title":"Comput. Speech Lang."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/08039488.2019.1694698","article-title":"The functional impact of cognition in adults with autism spectrum disorders","volume":"74","author":"Nyrenius","year":"2019","journal-title":"Nordic J. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10802-018-0493-8","article-title":"Childhood Executive Function Predicts Later Autistic Features and Adaptive Behavior in Young Autistic People: A 12-Year Prospective Study","volume":"47","author":"Kenny","year":"2019","journal-title":"J. Abnorm. Child Psychol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Keller, R. (2019). ASD and Intellectual Disability. Psychopathology in Adolescents and Adults with Autism Spectrum Disorders, Springer.","DOI":"10.1007\/978-3-030-26276-1"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neubiorev.2017.06.005","article-title":"Conceptualising compensation in neurodevelopmental disorders: Reflections from autism spectrum disorder","volume":"80","author":"Livingston","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103882","DOI":"10.1016\/j.ridd.2021.103882","article-title":"ADHD severity as a predictor of cognitive task performance in children with Autism Spectrum Disorder (ASD)","volume":"111","author":"Mansour","year":"2021","journal-title":"Res. Dev. Disabil."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Cornelis, M.C., Wang, Y., Holland, T., Agarwal, P., Weintraub, S., and Morris, M.C. (2019). Age and cognitive decline in the UK Biobank. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0213948"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/brain\/awaa088","article-title":"Microglial activation and tau burden predict cognitive decline in Alzheimer\u2019s disease","volume":"143","author":"Malpetti","year":"2020","journal-title":"Brain"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jalz.2010.04.005","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer\u2019s disease","volume":"7","author":"Marshall","year":"2011","journal-title":"Alzheimers Dement."},{"key":"ref_58","unstructured":"Alzheimer Association (2019). Early Signs and Symptoms of Alzheimer\u2019s Alzheimer\u2019s and Dementia, Alzheimer Association."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0269881120972331","article-title":"Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer\u2019s disease: Machine learning approaches","volume":"35","author":"Chang","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fpsyt.2018.00050","article-title":"Prevalence and risk factors of anxiety in a clinical Dutch sample of children with an autism spectrum disorder","volume":"9","author":"Wijnhoven","year":"2018","journal-title":"Front Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/aur.2063","article-title":"The neurobiological presentation of anxiety in autism spectrum disorder: A systematic review","volume":"12","author":"McVey","year":"2019","journal-title":"Autism Res."},{"key":"ref_62","first-page":"323","article-title":"The presentation and classification of anxiety in autism spectrum disorder","volume":"19","author":"Kerns","year":"2012","journal-title":"Clin. Psychol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.rasd.2013.09.005","article-title":"The relationship of comorbid anxiety symptom severity and challenging behaviors in infants and toddlers with autism spectrum disorder","volume":"7","author":"Cervantes","year":"2013","journal-title":"Res. Autism Spectr. Disord."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1007\/s10803-014-2184-9","article-title":"A systematic review of treatments for anxiety in youth with autism spectrum disorders","volume":"44","author":"Vasa","year":"2014","journal-title":"J. Autism Dev. Disord."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.rasd.2010.02.006","article-title":"Anxiety symptoms across the lifespan in people diagnosed with autistic disorder","volume":"5","author":"Hess","year":"2011","journal-title":"Res. Autism Spectr. Disord."},{"key":"ref_66","first-page":"559","article-title":"Anxiety and depression from adolescence to old age in autism spectrum disorder","volume":"49","author":"Hedley","year":"2019","journal-title":"J. Autism Dev. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s10803-015-2361-5","article-title":"Co-occurring psychiatric disorders in preschool and elementary school-aged children with autism spectrum disorder","volume":"45","author":"Salazar","year":"2015","journal-title":"J. Autism Dev. Disord."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13229-021-00421-1","article-title":"Is social camouflaging associated with anxiety and depression in autistic adults?","volume":"12","author":"Hull","year":"2021","journal-title":"Mol. Autism."},{"key":"ref_69","first-page":"141","article-title":"Depression in Alzheimer\u2019s disease: A Delphi consensus on etiology, risk factors, and clinical management","volume":"12","author":"Grandas","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"17r11772","DOI":"10.4088\/JCP.17r11772","article-title":"Meta-analysis of the prevalence of major depressive disorder among older adults with dementia","volume":"79","author":"Asmer","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1176\/appi.ajp.162.11.2086","article-title":"The construct of minor and major depression in Alzheimer\u2019s disease","volume":"162","author":"Starkstein","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pediatrneurol.2012.05.007","article-title":"Sleep in children with autism spectrum disorder","volume":"47","author":"Kotagal","year":"2012","journal-title":"Pediatric Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40489-013-0009-y","article-title":"Sleep problems in autism spectrum disorder: A literature review","volume":"1","author":"Mannion","year":"2014","journal-title":"J. Autism Dev. Disord."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/npr2.12170","article-title":"Similarity of subjective symptoms between autism spectrum disorder and attention-deficit\/hyperactivity disorder in adults: Preliminary findings","volume":"41","author":"Nakagawa","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.jagp.2021.01.108","article-title":"Circadian Rhythm Disturbance in Agitation of Alzheimer\u2019s disease","volume":"29","author":"Outen","year":"2021","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1038\/s41380-020-0663-2","article-title":"Sleep duration, brain structure, and psychiatric and cognitive problems in children","volume":"26","author":"Cheng","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41398-021-01212-1","article-title":"Disrupted-in-schizophrenia 1 enhances the quality of circadian rhythm by stabilizing BMAL1","volume":"11","author":"Lee","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"101902","DOI":"10.1016\/j.pneurobio.2020.101902","article-title":"Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer\u2019s disease","volume":"197","author":"Kent","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: Revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnagi.2017.00077","article-title":"A Bayesian Model for the Prediction and Early Diagnosis of Alzheimer\u2019s disease","volume":"9","author":"Alexiou","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fnins.2019.00349","article-title":"Neurological diseases with autism spectrum disorder: Role of ASD risk genes","volume":"13","author":"Xiong","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Santos, J.X., Rasga, C., Marques, A.R., Martiniano, H.F., Asif, M., Vilela, J., Oliveira, G., and Vicente, A.M. (2019). A role for gene-environment interactions in Autism Spectrum Disorder is suggested by variants in genes regulating exposure to environmental factors. bioRxiv, 520544.","DOI":"10.1101\/520544"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Hoffmann, A., and Spengler, D. (2021). Chromatin Remodeler CHD8 in Autism and Brain Development. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020366"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/jnr.24560","article-title":"Dysfunction of the corticostriatal pathway in autism spectrum disorders","volume":"98","author":"Li","year":"2020","journal-title":"J. Neurosci Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fncel.2014.00276","article-title":"Synaptic proteins and receptors defects in autism spectrum disorders","volume":"8","author":"Chen","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1093\/hmg\/ddv273","article-title":"Genetics and genomics of autism spectrum disorder: Embracing complexity","volume":"24","author":"Buxbaum","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/humu.22237","article-title":"A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder","volume":"33","author":"Puffenberger","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/mp.2017.140","article-title":"Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders","volume":"22","author":"Li","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41598-020-78654-y","article-title":"Multiplex gene and phenotype network to characterize shared genetic pathways of epilepsy and autism","volume":"11","author":"Peng","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Rahbar, M.H., Samms-Vaughan, M., Saroukhani, S., Bressler, J., Hessabi, M., Grove, M.L., Shakspeare-Pellington, S., Loveland, K.A., Beecher, C., and McLaughlin, W. (2021). Associations of Metabolic Genes (GSTT1, GSTP1, GSTM1) and Blood Mercury Concentrations Differ in Jamaican Children with and without Autism Spectrum Disorder. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18041377"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"44155","DOI":"10.1038\/srep44155","article-title":"Genome-wide copy number variation analysis in a Chinese autism spectrum disorder cohort","volume":"7","author":"Guo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature11737","article-title":"FMRP targets distinct mRNA sequence elements to regulate protein expression","volume":"492","author":"Ascano","year":"2012","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13148-020-00995-2","article-title":"Sperm DNA methylation epimutation biomarker for paternal offspring autism susceptibility","volume":"13","author":"Garrido","year":"2021","journal-title":"Clin. Epigenet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbrc.2014.08.108","article-title":"Genomic and genetic aspects of autism spectrum disorder","volume":"452","author":"Liu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/1362361320965074","article-title":"Autism and Williams syndrome: Dissimilar socio-cognitive profiles with similar patterns of abnormal gene expression in the blood","volume":"25","author":"Niego","year":"2021","journal-title":"Autism"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer\u2019s disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"105.e1","DOI":"10.1016\/j.neurobiolaging.2021.03.011","article-title":"Investigation of the role of matrix metalloproteinases in the genetic etiology of Alzheimer\u2019s disease","volume":"104","author":"Hoogmartens","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Lanoisel\u00e9e, H.M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.C., Pasquier, F., Rollin-Sillaire, A., and Martinaud, O. (2017). APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002270"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/exnr.1994.1108","article-title":"Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer\u2019s disease and in age-matched controls","volume":"128","author":"Han","year":"1994","journal-title":"Exp. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Qian, J., Wolters, F.J., Beiser, A., Haan, M., Ikram, M.A., Karlawish, J., Langbaum, J.B., Neuhaus, J.M., Reiman, E.M., and Roberts, J.S. (2017). APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002254"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13229-017-0157-5","article-title":"Identification of autism-related MECP2 mutations by whole-exome sequencing and functional validation","volume":"8","author":"Wen","year":"2017","journal-title":"Mol. Autism"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fnagi.2020.616614","article-title":"AD7c-NTP Impairs Adult Striatal Neurogenesis by Affecting the Biological Function of MeCP2 in APP\/PSl Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_104","first-page":"1619","article-title":"Discovery of autism\/intellectual disability somatic mutations in Alzheimer\u2019s brains: Mutated ADNP cytoskeletal impairments and repair as a case study","volume":"26","author":"Hadar","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"ref_105","first-page":"533","article-title":"Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer\u2019s disease","volume":"121","author":"Andreoli","year":"2014","journal-title":"J. Neural Transm."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1038\/srep08296","article-title":"Association of genetic variants of GRIN2B with autism","volume":"5","author":"Pan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jphs.2016.10.002","article-title":"Human GRIN2B variants in neurodevelopmental disorders","volume":"132","author":"Hu","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10072-019-04113-w","article-title":"Identification of common genetic markers of paroxysmal neurological disorders using a network analysis approach","volume":"41","author":"Ilyas","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuron.2019.05.037","article-title":"The autism-associated gene Scn2a contributes to dendritic excitability and synaptic function in the prefrontal cortex","volume":"103","author":"Spratt","year":"2019","journal-title":"Neuron"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.neurobiolaging.2015.09.004","article-title":"A truncating mutation in Alzheimer\u2019s disease inactivates neuroligin-1 synaptic function","volume":"36","author":"Ruiz","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng1136","article-title":"Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism","volume":"34","author":"Jamain","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/nmt.14.54","article-title":"New insights into Alzheimer\u2019s disease pathogenesis: The involvement of neuroligins in synaptic malfunction","volume":"5","author":"Sindi","year":"2015","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2007.09.005","article-title":"Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene","volume":"82","author":"Abrahams","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.molmed.2012.01.003","article-title":"What does CNTNAP2 reveal about autism spectrum disorder?","volume":"18","author":"Geschwind","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/YPG.0000000000000090","article-title":"A genome-wide association study of late-onset Alzheimer\u2019s disease in a Japanese population","volume":"25","author":"Hirano","year":"2015","journal-title":"Psychiatry Genet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40142-020-00182-y","article-title":"Alzheimer\u2019s disease Genetics: Review of Novel Loci Associated with Disease","volume":"8","author":"Santana","year":"2020","journal-title":"Curr. Genet. Med. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-160091","article-title":"Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer\u2019s Disease in a Family with Several Generations of APOE-\u025b4 Homozygosity","volume":"56","author":"Louwersheimer","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ng.3681","article-title":"TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons","volume":"48","author":"Caubit","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.biopsych.2019.03.974","article-title":"Postnatal Tshz3 deletion drives altered corticostriatal function and autism spectrum disorder\u2013like behavior","volume":"86","author":"Chabbert","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.braindev.2012.05.013","article-title":"SHANK3 as an autism spectrum disorder-associated gene","volume":"35","author":"Uchino","year":"2013","journal-title":"Brain Dev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.pnpbp.2017.11.019","article-title":"SHANK genes in autism: Defining therapeutic targets","volume":"84","author":"Mossa","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1933","article-title":"Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders","volume":"39","author":"Durand","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fneur.2019.00028","article-title":"microRNA-34a (miRNA-34a) mediated down-regulation of the post-synaptic cytoskeletal element SHANK3 in sporadic Alzheimer\u2019s disease (AD)","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-020-00412-8","article-title":"Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model","volume":"12","author":"Matas","year":"2021","journal-title":"Mol. Autism"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.conb.2012.05.004","article-title":"PTEN signaling in autism spectrum disorders","volume":"22","author":"Zhou","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nn.4225","article-title":"PTEN recruitment controls synaptic and cognitive function in Alzheimer\u2019s models","volume":"19","author":"Knafo","year":"2016","journal-title":"Nat. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nn.4248","article-title":"Targeting PTEN interactions for Alzheimer\u2019s disease","volume":"9","author":"Frere","year":"2016","journal-title":"Nat. Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Matsuda, S., Nakagawa, Y., Tsuji, A., Kitagishi, Y., Nakanishi, A., and Murai, T. (2018). Implications of PI3K\/AKT\/PTEN signaling on superoxide dismutases expression and in the pathogenesis of Alzheimer\u2019s disease. Diseases, 6.","DOI":"10.3390\/diseases6020028"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13229-017-0168-2","article-title":"Zebrafish knockout of Down syndrome gene, DYRK1A, shows social impairments relevant to autism","volume":"8","author":"Kim","year":"2017","journal-title":"Mol. Autism"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/mp.2015.5","article-title":"Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID","volume":"21","author":"Coe","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2017.06.010","article-title":"Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer\u2019s disease phenotypes","volume":"106","author":"Rueda","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/cn300094k","article-title":"Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: A new avenue for a disease modifying treatment of Alzheimer\u2019s?","volume":"3","author":"Smith","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.psychres.2015.09.021","article-title":"Genetic analysis of the RELN gene: Gender specific association with Alzheimer\u2019s disease","volume":"230","author":"Janka","year":"2015","journal-title":"Psychiatry Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-2008-14308","article-title":"The RELN locus in Alzheimer\u2019s disease","volume":"14","author":"Seripa","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fncel.2016.00084","article-title":"RELN mutations in autism spectrum disorder","volume":"10","author":"Lammert","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2040-2392-4-23","article-title":"Increased gene expression of FOXP1 in patients with autism spectrum disorders","volume":"4","author":"Chien","year":"2013","journal-title":"Mol. Autism"},{"key":"ref_137","first-page":"610345","article-title":"Alzheimer\u2019s patient brain myeloid cells exhibit enhanced aging and unique transcriptional activation","volume":"1","author":"Srinivasan","year":"2019","journal-title":"BioRxiv"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"eabd2827","DOI":"10.1126\/sciadv.abd2827","article-title":"Autism-linked gene FoxP1 selectively regulates the cultural transmission of learned vocalizations","volume":"7","author":"Koch","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_139","first-page":"2757","article-title":"Determine Some Mutations in the Foxp1 Gene in Autistic Patients in Baghdad Governorate","volume":"11","author":"Kadhim","year":"2021","journal-title":"Ann. Rom. Soc. Cell Biol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","article-title":"A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease","volume":"4","author":"Seyfried","year":"2017","journal-title":"Cell Syst."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Rolland, T., Cliquet, F., Anney, R.J., Traut, N., Mathieu, A., Huguet, G., Leblond, C.S., Douard, E., Amsellem, F., and Malesys, S. (2021). Towards a gene-level map of resilience to genetic variants associated with autism. medRxiv.","DOI":"10.1101\/2021.02.12.21251621"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000509799","article-title":"The Genetics Analysis of Molecular Pathogenesis for Alzheimer\u2019s Disease","volume":"83","author":"Lin","year":"2020","journal-title":"Eur. Neurol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-018-1073-7","article-title":"Meta-analysis of the association between GABA receptor polymorphisms and autism spectrum disorder (ASD)","volume":"65","author":"Mahdavi","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1093\/hmg\/ddx295","article-title":"Ube3a deficiency inhibits amyloid plaque formation in APPswe\/PS1\u03b4E9 mouse model of Alzheimer\u2019s disease","volume":"26","author":"Singh","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"12503","DOI":"10.1074\/jbc.M117.788448","article-title":"The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt\/\u03b2-catenin pathway by inhibiting the proteasome","volume":"292","author":"Jason","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s42003-019-0350-5","article-title":"Dysfunction of the ubiquitin ligase E3A Ube3A\/E6-AP contributes to synaptic pathology in Alzheimer\u2019s disease","volume":"2","author":"Olabarria","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1093\/brain\/aww205","article-title":"Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss","volume":"139","author":"Tiwari","year":"2016","journal-title":"Brain"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/ahg.12121","article-title":"Common regulatory variants of CYFIP1 contribute to susceptibility for autism spectrum disorder (ASD) and classical autism","volume":"79","author":"Wang","year":"2015","journal-title":"Ann. Hum. Genet."},{"key":"ref_149","first-page":"28","article-title":"Low expression of aging-related NRXN3 is associated with Alzheimer disease: A systematic review and meta-analysis","volume":"97","author":"Zheng","year":"2018","journal-title":"Medicine"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41380-020-00944-8","article-title":"Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions","volume":"26","author":"Tromp","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-190147","article-title":"SNARE complex polymorphisms associate with alterations of visual selective attention in Alzheimer\u2019s Disease","volume":"69","author":"Costa","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3389\/fnins.2018.00699","article-title":"The molecular and neuropathological consequences of genetic risk for Alzheimer\u2019s dementia","volume":"12","author":"Tasaki","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.01.007","article-title":"Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors","volume":"2","author":"Cartier","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pnpbp.2017.11.016","article-title":"PSD95: A synaptic protein implicated in schizophrenia or autism?","volume":"82","author":"Coley","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5296\/jbls.v9i1.12474","article-title":"Identification of Key Genes Related with Alzheimer\u2019s Disease Treatment Through Bioinformatics Analysis","volume":"9","author":"Liu","year":"2018","journal-title":"J. Biol. Life Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e919311-1","DOI":"10.12659\/MSM.919311","article-title":"Related network and differential expression analyses identify nuclear genes and pathways in the hippocampus of Alzheimer disease","volume":"26","author":"Quan","year":"2020","journal-title":"Medical science monitor: Int. Med. J. Exp. Clin. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11481-018-9781-x","article-title":"Tau phosphorylation is impacted by rare AKAP9 mutations associated with Alzheimer disease in African Americans","volume":"13","author":"Ikezu","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1038\/tp.2013.48","article-title":"AKAPs integrate genetic findings for autism spectrum disorders","volume":"3","author":"Poelmans","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fgene.2016.00107","article-title":"Do copy number changes in CACNA2D2, CACNA2D3, and CACNA1D constitute a predisposing risk factor for Alzheimer\u2019s disease?","volume":"7","author":"Villela","year":"2016","journal-title":"Front. Genet."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.conb.2014.10.015","article-title":"Autism spectrum disorders: From genes to neurobiology","volume":"30","author":"Willsey","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neubiorev.2016.12.036","article-title":"Features of the broader autism phenotype in people with epilepsy support shared mechanisms between epilepsy and autism spectrum disorder","volume":"75","author":"Richard","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4103\/njcp.njcp_282_16","article-title":"Oxidative stress markers and genetic polymorphisms of glutathione S-transferase T1, M1, and P1 in a subset of children with autism spectrum disorder in Lagos, Nigeria","volume":"20","author":"Oshodi","year":"2017","journal-title":"Niger. J. Clin. Pract."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/01616412.2017.1390902","article-title":"Association of glutathione S-transferases M1, P1 and T1 variations and risk of late-onset Alzheimer\u2019s disease","volume":"40","author":"Jafarian","year":"2018","journal-title":"Neurol. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11689-011-9084-5","article-title":"FMR1 premutation and full mutation molecular mechanisms related to autism","volume":"3","author":"Hagerman","year":"2011","journal-title":"J. Neurodev. Disord."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fgene.2014.00360","article-title":"Fragile X mental retardation protein expression in Alzheimer\u2019s disease","volume":"5","author":"Renoux","year":"2014","journal-title":"Front. Genet."},{"key":"ref_166","first-page":"1","article-title":"Maternal Pragmatic Language Difficulties in the FMR1 Premutation and the Broad Autism Phenotype: Associations with Individual and Family Outcomes","volume":"4","author":"Klusek","year":"2021","journal-title":"J. Autism Dev. Disord."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/YPG.0b013e32809c2f75","article-title":"Investigation of potential gene\u2013gene interactions between APOE and RELN contributing to autism risk","volume":"17","author":"Jaworski","year":"2007","journal-title":"Psychiatr. Genet."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Lee, E.G., Tulloch, J., Chen, S., Leong, L., Saxton, A.D., Kraemer, B., Darvas, M., Keene, C.D., Shutes-David, A., and Todd, K. (2020). Redefining transcriptional regulation of the APOE gene and its association with Alzheimer\u2019s disease. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227667"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fnins.2021.630502","article-title":"APOE and Alzheimer\u2019s disease: From lipid transport to physiopathology and therapeutics","volume":"15","author":"Husain","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_170","first-page":"4749","article-title":"APOE hypermethylation is associated with autism spectrum disorder in a Chinese population","volume":"15","author":"Hu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mp.2016.134","article-title":"Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism","volume":"21","author":"Westmark","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s12035-016-9721-9","article-title":"Elevated serum brain-derived neurotrophic factor (BDNF) but not BDNF gene Val66Met polymorphism is associated with autism spectrum disorders","volume":"54","author":"Meng","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejpn.2015.03.005","article-title":"Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood","volume":"19","author":"Bryn","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"192-e11","DOI":"10.1016\/j.neurobiolaging.2016.12.023","article-title":"Female-specific effect of the BDNF gene on Alzheimer\u2019s disease","volume":"53","author":"Li","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"118020","DOI":"10.1016\/j.lfs.2020.118020","article-title":"The role of CREB and BDNF: Neurobiology and treatment of Alzheimer\u2019s disease","volume":"257","author":"Amidfar","year":"2020","journal-title":"Life Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"82390","DOI":"10.18632\/oncotarget.19326","article-title":"Immunological cytokine profiling identifies TNF-\u03b1 as a key molecule dysregulated in autistic children","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-016-0054-4","article-title":"The dual roles of cytokines in Alzheimer\u2019s disease: Update on interleukins, TNF-\u03b1, TGF-\u03b2 and IFN-\u03b3","volume":"5","author":"Zheng","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11033-019-05119-5","article-title":"Psychiatric disorders and SLC6A4 gene variants: Possible effects on alcohol dependence and alzheimer\u2019s disease","volume":"47","author":"Mandelli","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ajmg.b.31003","article-title":"Association and gene\u2013gene interaction of SLC6A4 and ITGB3 in autism","volume":"153","author":"Ma","year":"2010","journal-title":"Am. J. Med Genet. Part B Neuropsychiatr. Genet."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.2011.1638","article-title":"Neuron number and size in prefrontal cortex of children with autism","volume":"306","author":"Courchesne","year":"2011","journal-title":"JAMA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuron.2007.10.016","article-title":"Mapping early brain development in autism","volume":"56","author":"Courchesne","year":"2007","journal-title":"Neuron"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/mp.2016.95","article-title":"Altered proliferation and networks in neural cells derived from idiopathic autistic individuals","volume":"22","author":"Marchetto","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.braindev.2004.11.010","article-title":"Early motor disturbances in Rett syndrome and its pathophysiological importance","volume":"27","author":"Segawa","year":"2005","journal-title":"Brain Dev."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fnana.2014.00097","article-title":"Dendritic spine dysgenesis in Rett syndrome","volume":"8","author":"Xu","year":"2014","journal-title":"Front. Neuroanat."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.12688\/f1000research.8156.1","article-title":"Reduced neuronal size and mTOR pathway activity in the Mecp2 A140V Rett syndrome mouse model","volume":"5","author":"Rangasamy","year":"2016","journal-title":"F1000Research"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-neuro-080317-061747","article-title":"Abnormal mTOR Activation in Autism","volume":"41","author":"Winden","year":"2018","journal-title":"Ann. Rev. Neurosci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fped.2017.00043","article-title":"Dynamic Akt\/mTOR signaling in children with autism spectrum disorder","volume":"5","author":"Onore","year":"2017","journal-title":"Front. Pediatrics"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"20150429","DOI":"10.1098\/rstb.2015.0429","article-title":"Impairments of neural circuit function in Alzheimer\u2019s disease","volume":"371","author":"Busche","year":"2016","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1523\/JNEUROSCI.6159-08.2009","article-title":"Deletion of the \u03b17 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer\u2019s disease","volume":"29","author":"Dziewczapolski","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.euroneuro.2014.02.004","article-title":"Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis","volume":"24","author":"Gabriele","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrn2284","article-title":"Targeting the murine serotonin transporter: Insights into human neurobiology","volume":"9","author":"Murphy","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature09972","article-title":"A transient placental source of serotonin for the fetal forebrain","volume":"472","author":"Bonnin","year":"2011","journal-title":"Nature"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mad.2005.09.016","article-title":"Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer\u2019s disease","volume":"127","author":"Lanari","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.concog.2005.09.009","article-title":"The role of the extrapersonal brain systems in religious activity","volume":"15","author":"Previc","year":"2006","journal-title":"Conscious. Cogn."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.wnf.0000186651.96351.2e","article-title":"Effect of levodopa on healthy volunteers\u2019 facial emotion perception: An FMRI study","volume":"28","author":"Delaveau","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neubiorev.2005.07.002","article-title":"The orbitofrontal-amygdala circuit and self-regulation of social\u2013emotional behavior in autism","volume":"30","author":"Bachevalier","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and dopamine receptors in Alzheimer\u2019s disease: A systematic review and network meta-analysis","volume":"11","author":"Pan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1021\/acschemneuro.8b00122","article-title":"Regulatory activities of dopamine and its derivatives toward metal-free and metal-induced amyloid-\u03b2 aggregation, oxidative stress, and inflammation in Alzheimer\u2019s disease","volume":"9","author":"Nam","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Eltokhi, A., Santuy, A., Merchan-Perez, A., and Sprengel, R. (2021). Glutamatergic dysfunction and synaptic ultrastructural alterations in schizophrenia and autism spectrum disorder: Evidence from human and rodent studies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010059"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-201146","article-title":"Metabotropic glutamate receptors in Alzheimer\u2019s disease synaptic dysfunction: Therapeutic opportunities and hope for the future","volume":"78","author":"Srivastava","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/mp.2017.245","article-title":"Dynamic landscape of the local translation at activated synapses","volume":"23","author":"Khlebodarova","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archgenpsychiatry.2011.145","article-title":"Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders: A longitudinal study","volume":"69","author":"Nordahl","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1038\/sj.mp.4001169","article-title":"Abnormal early brain development in autism","volume":"7","author":"Courchesne","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2174\/1389203718666170911145321","article-title":"Proteins commonly linked to autism spectrum disorder and Alzheimer\u2019s disease","volume":"19","author":"Alexiou","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"26697","DOI":"10.1074\/jbc.M112.424747","article-title":"SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region","volume":"288","author":"Mameza","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Bucher, M., Niebling, S., Han, Y., Molodenskiy, D., Kreienkamp, H.J., Svergun, D., Kim, E., Kostyukova, A.S., Kreutz, M.R., and Mikhaylova, M. (2021). Autism associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses. bioRxiv.","DOI":"10.1101\/2020.12.31.424970"},{"key":"ref_209","first-page":"312","article-title":"Alterations in micro RNA-messenger RNA (miRNA-mRNA) coupled signaling networks in sporadic Alzheimer\u2019s disease (AD) hippocampal CA1","volume":"7","author":"Jaber","year":"2017","journal-title":"J. Alzheimers Dis. Parkinsonism"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0b013e3182166dc7","article-title":"Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links","volume":"76","author":"Sokol","year":"2011","journal-title":"Neurology"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ajhg.2013.09.013","article-title":"The roles of FMRP-regulated genes in autism spectrum disorder: Single-and multiple-hit genetic etiologies","volume":"93","author":"Steinberg","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1007\/s12035-015-9229-8","article-title":"Opposite dysregulation of fragile-X mental retardation protein and heteronuclear ribonucleoprotein C protein associates with enhanced APP translation in Alzheimer disease","volume":"53","author":"Borreca","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/ajmg.a.38205","article-title":"Familial 18q12. 2 deletion supports the role of RNA-binding protein CELF4 in autism spectrum disorders","volume":"173","author":"Barone","year":"2017","journal-title":"Am. J. Med. Genet."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnint.2019.00049","article-title":"Peripheral amyloid precursor protein derivative expression in fragile X syndrome","volume":"13","author":"McLane","year":"2019","journal-title":"Fronti. Integr. Neurosci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-3-10","article-title":"MicroRNAs can regulate human APP levels","volume":"3","author":"Patel","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"ref_216","first-page":"1","article-title":"MicroRNA-298 reduces levels of human amyloid-\u03b2 precursor protein (APP), \u03b2-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties","volume":"15","author":"Chopra","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4161\/cib.3.6.13172","article-title":"Post-transcriptional regulation of amyloid precursor protein by microRNAs and RNA binding proteins","volume":"3","author":"Ruberti","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1306.001","article-title":"Iron metabolism and the IRE\/IRP regulatory system: An update","volume":"1012","author":"Pantopoulos","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13024-017-0218-4","article-title":"Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases","volume":"12","author":"Zhou","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nsmb.1815","article-title":"hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies","volume":"17","author":"Lee","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"19889","DOI":"10.1074\/jbc.AC119.010078","article-title":"The RNA-binding protein FMRP facilitates the nuclear export of N6-methyladenosine\u2013containing mRNAs","volume":"294","author":"Hsu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.emboj.7601468","article-title":"A role for hnRNP C1\/C2 and Unr in internal initiation of translation during mitosis","volume":"26","author":"Schepens","year":"2007","journal-title":"EMBO J."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.1038\/s41598-020-66394-y","article-title":"FMRP Regulates the Nuclear Export of Adam9 and Psen1 mRNAs: Secondary Analysis of an N 6-Methyladenosine Dataset","volume":"10","author":"Westmark","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41398-020-0709-x","article-title":"Rivastigmine modifies the \u03b1-secretase pathway and potentially early Alzheimer\u2019s disease","volume":"10","author":"Ray","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"eaao4827","DOI":"10.1126\/science.aao4827","article-title":"Secreted amyloid-\u03b2 precursor protein functions as a GABABR1a ligand to modulate synaptic transmission","volume":"363","author":"Rice","year":"2019","journal-title":"Science"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Tang, B.L. (2019). Amyloid precursor protein (APP) and GABAergic neurotransmission. Cells, 8.","DOI":"10.3390\/cells8060550"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Ray, B., Long, J.M., Sokol, D.K., and Lahiri, D.K. (2011). Increased secreted amyloid precursor protein-\u03b1 (sAPP\u03b1) in severe autism: Proposal of a specific, anabolic pathway and putative biomarker. PLoS ONE, 22.","DOI":"10.1371\/journal.pone.0020405"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"16253","DOI":"10.1038\/s41598-017-16440-z","article-title":"Disrupted brain network in children with autism spectrum disorder","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.1038\/srep26052","article-title":"Finding novel distinctions between the sAPP\u03b1-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue","volume":"6","author":"Ray","year":"2016","journal-title":"Sci Rep."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fpsyt.2019.00165","article-title":"Novel contribution of secreted amyloid-\u03b2 precursor protein to white matter brain enlargement in autism spectrum disorder","volume":"10","author":"Sokol","year":"2019","journal-title":"Front. Ppsychiatry"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/11\/1635\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:25:44Z","timestamp":1760167544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/11\/1635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":230,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["biom11111635"],"URL":"https:\/\/doi.org\/10.3390\/biom11111635","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]}}}